MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'arcoxia'. Sat, 03 Sep 2011 02:58:33 +0100 http://www.medworm.com/index.php?rid=1556512&cid=t_112256_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F323189744%2F So what else is new? In yet another round-up that discusses the slow rate of approvals compared with the number of FDA warnings, rejections and delays, The Wall Street Journal gathers some recent developments to re-examine the issue once again. Last year, the FDA approved 19 new meds, the fewest in 24 years, and announced about 75 new or revised Black Box warnings, which was twice the number in 2004. The number of approvable letters, which postpone FDA decisions pending more data, increased by 40 percent last year, according to Sagient Research, the paper writes. Meanwhile, pharma grouses the European Medicines Agency has approved several drugs that haven’t passed muster with the FDA, including Galvus, Prexige and Acomplia. The FDA has delayed approval of Glaxo’s HPV vaccine, ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1556512 Mon, 30 Jun 2008 11:42:48 +0100 1556512 http://www.medworm.com/index.php?rid=1551903&cid=t_112256_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F321261842%2F This is an exciting thought, is it not? But before you head off, make sure you look twice, even three times, at your to-do list. And keep one eye on all those important developments. Here are a few…. Wyeth Puts Centrum Account Up For Review (Advertising Age) EMEA Warns About Anemia Drugs (Yahoo/Reuters) South Korea Rules Against Pfizer Over Lipitor Patent (Thomson Financial) Merck’s Arcoxia Needs Added Warning In Europe (Bloomberg News) (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1551903 Fri, 27 Jun 2008 11:32:37 +0100 1551903 http://www.medworm.com/index.php?rid=728718&cid=t_112256_150_f&fid=35781&url=http%3A%2F%2Fwww.qdinformation.com%2Fqdisblog%2F2007%2F04%2F28%2Ffda-rejects-mercks-arcoxia%2F It isn’t surprising that the FDA rejected Merck’s NDA for Arcoxia, its follow on to Vioxx since an advisory committee already voted 20-1 against its approval. Forbes has an article on it. FDA Rejects Merck’s Vioxx Successor - Forbes.com: It is interesting to note though that Arrcoxia is on sale in 63 countries world-wide already. It be be interesting to see what effect if any it has on world-wide sales. Technorati Tags: Arcoxia, Merck, Vioxx Copyright © 2007 QDIS Blog. This Feed is for personal non-commercial use only. If you are not reading this material in your news aggregator, the site you are looking at is guilty of copyright infringement. Please contact legal@qdinformation.com so we can take action immediately.Plugin by Taragana (Source: QDIS Blog) QDIS Blog blogs http://www.medworm.com/rss/comments.php?id=728718 Sat, 28 Apr 2007 17:24:38 +0100 728718 http://www.medworm.com/index.php?rid=545814&cid=t_112256_150_f&fid=34768&url=http%3A%2F%2Fpharmagossip.blogspot.com%2F2007%2F04%2Fmerck-arcoxia-clearly-killing-people-in.html Food and Drug Administration whistle-blower David Graham isn't giving up.He's not content with helping to keep Merck's drug Arcoxia (the son or daughter Vioxx, depending upon who you read) off just the U.S. market, because that still leaves 63 countries in which the arthritis medication is sold.Graham, of the agency's Office of Surveillance and Epidemiology, warned an FDA advisory panel Thursday that Arcoxia would be "a potential public-health disaster" because it raises heart attack and stroke risk. The panel voted 20 to 1 against recommending approval of Arcoxia, which critics have likened to Vioxx, the arthritis drug Merck withdrew in September 2004 because of cardiovascular safety concerns.The FDA typically follows the advice of its advisory panels.Graham said Friday that he wants to f... PharmaGossip blogs http://www.medworm.com/rss/comments.php?id=545814 Mon, 16 Apr 2007 06:00:00 +0100 545814